The 32 most recent market catalysts affecting $CNC, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.
Nov 16, 2026
Corporate Catalyst
Bullish
Impact 55
Bernstein Adjusts Price Target on Centene to $90 From $79
Bernstein, a prominent financial firm, has adjusted its price target for Centene Corporation (CNC) upwards from $79 to $90. This action signifies a revised and more favorable valua…
Nov 13, 2026
Corporate Catalyst
Bearish
Impact 55
Centene to Lay Off 69 Employees in Hawaii Following Medicaid Market Exit
Centene Corporation is terminating 69 employees in Hawaii as a direct consequence of its decision to withdraw from the state's Medicaid market (Med-QUEST) by the end of 2026. This …
Nov 12, 2026
Corporate Catalyst
Bullish
Impact 60
Centene and Other Insurers Partner with Duet to Expand Network Access
Centene, Anthem, Cigna, and Molina have formed a partnership with Duet to gain access to a unified network of independent nurse practitioner-owned clinics. This collaboration is si…
Nov 12, 2026
Corporate Catalyst
Neutral
Impact 55
Ambetter from Meridian Returns to Metro Detroit for 2027 Marketplace Open Enrollment
Centene Corporation announced that its Ambetter from Meridian health plan will return to the Metro Detroit area for the 2027 Marketplace open enrollment. This is a strategic move t…
Nov 10, 2026
Corporate Catalyst
Bearish
Impact 75
Congressional Inquiry into Centene's Role in Health Coverage Terminations
Centene and other major health insurers are under formal inquiry by U.S. Senators regarding their compliance in terminating health coverage for 760,000 federal marketplace enrollee…
Nov 5, 2026
Corporate Catalyst
Bearish
Impact 85
US Department of Justice Intervenes in Whistleblower Lawsuit Against Centene Corporation
The U.S. Department of Justice has joined a whistleblower lawsuit against Centene, alleging the company violated the False Claims Act by enrolling ineligible individuals in its Med…
Nov 2, 2026
Corporate Catalyst
Bullish
Impact 55
Goldman Sachs Adjusts Centene Price Target to $62 From $56
Goldman Sachs has updated its financial outlook for Centene Corporation, raising its price target from $56 to $62. This change indicates that Goldman Sachs analysts see increased v…
Nov 2, 2026
Corporate Catalyst
Bullish
Impact 55
Deutsche Bank Adjusts Centene Price Target to $87 From $85
Deutsche Bank, a prominent financial institution, has updated its analysis of Centene Corporation, leading to a modest increase in its price target. This change, from $85 to $87, c…
Nov 2, 2026
Corporate Catalyst
Bullish
Impact 55
Truist Adjusts Price Target on Centene to $82 From $80, Maintains Buy Rating
Truist, a financial services firm, has adjusted its price target for Centene Corporation (CNC) from $80 to $82 and maintained its 'Buy' rating. This action signals a slightly impro…
Oct 30, 2026
Corporate Catalyst
Bullish
Impact 55
Wells Fargo Maintains Equal-Weight Rating on Centene and Raises Price Target
Wells Fargo has updated its outlook on Centene Corporation, maintaining an 'Equal-Weight' rating but raising the price target to $75 from $69. This 8.7% increase in the target pric…
Oct 29, 2026
Corporate Catalyst
Bullish
Impact 55
J.P. Morgan Maintains Hold Rating on Centene and Raises Price Target to $75
J.P. Morgan analyst John Stansel has reiterated a 'Hold' rating on Centene (CNC) but increased the price target from $67 to $75. This move suggests that while J.P. Morgan sees some…
Oct 28, 2026
Corporate Catalyst
Bullish
Impact 65
Cantor Fitzgerald Upgrades Centene to Overweight and Raises Price Target to $79
Cantor Fitzgerald's upgrade of Centene to Overweight and the increase in its price target to $79 reflects a more optimistic view of the company's future performance and valuation. …
Oct 27, 2026
Corporate Catalyst
Bullish
Impact 85
Centene Corporation Reports Q3 2026 Financial Results and Raises Full-Year Guidance
Centene Corporation announced strong Q3 2026 results and significantly raised its full-year guidance, which is a major positive catalyst for the company. This improved outlook is a…
Oct 13, 2026
Corporate Catalyst
Neutral
Impact 55
Centene To Launch Its National Performance-Based Gold Card Program In November 2026
Centene is implementing a 'Gold Card Program' starting November 2026, which will allow qualifying healthcare providers to bypass standard prior authorization for certain outpatient…
Sep 16, 2026
Corporate Catalyst
Neutral
Impact 75
Centene Reaffirms FY2026 GAAP EPS expected to be more than $3.11 vs $2.47 Est
Centene (CNC) filed an 8-K to reaffirm its fiscal year 2026 GAAP EPS guidance, stating it expects earnings to be more than $3.11. This is a significant disclosure because it is sub…
Sep 16, 2026
Corporate Catalyst
Neutral
Impact 65
Centene Reaffirms FY26 Adjusted Diluted EPS Guidance Of Greater Than $4.80
Centene's 8-K filing indicates that management will reaffirm its full-year 2026 GAAP diluted EPS guidance of greater than $3.11 and adjusted diluted EPS guidance of greater than $4…
Aug 17, 2026
Corporate Catalyst
Neutral
Impact 65
Centene's CFO Drew Asher To Step Down in December 2026 and Retire From Centene By End Of 2027; Chris Neczypor To Join As EVP abd CFO From January 1, 2027
The departure of a CFO, especially one with a long tenure, is always a notable event for a company. While the extended transition period for Drew Asher mitigates immediate shock, i…
Aug 4, 2026
Corporate Catalyst
Bullish
Impact 55
JP Morgan Maintains Neutral on Centene, Raises Price Target to $67
JP Morgan analyst John Stansel has updated his outlook on Centene (CNC) by raising the price target from $60 to $67, while keeping the 'Neutral' rating unchanged. This indicates th…
Aug 3, 2026
Corporate Catalyst
Bullish
Impact 55
Bernstein Maintains Outperform on Centene, Raises Price Target to $79
Bernstein analyst Lance Wilkes has raised the price target for Centene (CNC) from $68 to $79 while maintaining an Outperform rating. This action signals increased confidence from a…
Jul 29, 2026
Corporate Catalyst
Bullish
Impact 55
Barclays Maintains Overweight on Centene, Raises Price Target to $80
Barclays analyst Andrew Mok maintained an 'Overweight' rating on Centene and raised the price target from $75 to $80. This action signals continued confidence in Centene's performa…
Jul 29, 2026
Corporate Catalyst
Bullish
Impact 55
Baird Maintains Neutral on Centene, Raises Price Target to $66
Baird analyst Michael Ha reiterated a 'Neutral' rating on Centene (CNC) but raised the price target from $46 to $66. This substantial increase in the price target, despite the unch…
Jul 28, 2026
Corporate Catalyst
Bullish
Impact 85
Centene Finds Profit Growth Even as Medicaid Membership Softens
Centene's Q2 2026 results significantly exceeded analyst expectations for both earnings and revenue, prompting the company to raise its full-year guidance. This strong performance …
Jul 28, 2026
Corporate Catalyst
Bearish
Impact 85
Centene shares are trading lower after the company reported Q2 financial results. The CEO said the company is expecting a lower year-end membership.
Centene's Q2 earnings report, particularly the CEO's guidance for lower year-end membership, is a significant negative catalyst. This directly impacts the company's revenue project…
Jul 28, 2026
Corporate Catalyst
Bearish
Impact 85
Centene CEO Says Co Is Expecting Lower Year-End Membership Than Its Previous Outlook Through The Back Half Of The Year
Centene's CEO's statement about expecting lower year-end membership than previously anticipated is a significant corporate catalyst. This directly impacts the company's revenue pro…
Jul 28, 2026
Corporate Catalyst
Bullish
Impact 85
Centene FY2026 Adj EPS expected to be more than $4.80 vs $3.52 Est; Raises FY2026 Sales Guidance from $187.500B-$191.500B to $193.500B-$197.500B vs $191.020B Est
Centene (CNC) announced a substantial upward revision to its fiscal year 2026 financial guidance. The company now expects adjusted EPS to be more than $4.80, significantly higher t…
Jul 28, 2026
Corporate Catalyst
Neutral
Impact 75
Centene FY2026 GAAP EPS expected to be more than $3.11 vs $2.47 Est
Centene's 8-K filing reveals a substantial increase in its projected GAAP EPS for fiscal year 2026, moving from an estimated $2.47 to 'more than $3.11'. This represents a significa…
Jul 23, 2026
Corporate Catalyst
Bearish
Impact 75
Centene shares are trading lower amid possible sympathy with peer Molina Healthcare after the company reported Q2 financial results.
This headline indicates a 'sympathy trade' where one company's negative performance (Molina Healthcare) is impacting a peer (Centene) due to perceived industry-wide implications or…
Jul 22, 2026
Corporate Catalyst
Bearish
Impact 75
Centene shares are trading lower amid possible sympathy with peer Molina Healthcare after the company reported Q2 financial results.
This headline indicates a 'sympathy trade' where one company's negative news impacts a peer, even without direct news for the latter. Molina Healthcare's Q2 results likely containe…
Jul 16, 2026
Corporate Catalyst
Neutral
Impact 75
Medicaid's New Twice-A-Year Eligibility Check Starts In December: How To Keep Your Coverage And Which Stocks Feel It
A new federal budget law, effective December 2026, will require Medicaid expansion enrollees to undergo eligibility checks every six months, rather than annually. This administrati…
Jul 14, 2026
Corporate Catalyst
Bullish
Impact 55
TD Cowen Maintains Hold on Centene, Raises Price Target to $65
TD Cowen analyst Ryan Langston maintained a 'Hold' rating on Centene (CNC) but significantly raised the price target from $47 to $65. This action signals an increased confidence in…
Jul 14, 2026
Corporate Catalyst
Bullish
Impact 55
Truist Securities Maintains Buy on Centene, Raises Price Target to $78
Truist Securities analyst David Macdonald has updated his outlook on Centene, raising the price target to $78 from $71 while maintaining a 'Buy' rating. This action signals increas…
Jul 13, 2026
Corporate Catalyst
Bullish
Impact 55
Wells Fargo Maintains Equal-Weight on Centene, Raises Price Target to $69
Wells Fargo analyst Stephen Baxter maintained an 'Equal-Weight' rating on Centene (CNC) but significantly raised the price target from $56 to $69. This indicates that while the ana…
Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.